Physician

Karl Kirk Trimble, MD

According to 2025 Medicare claims, Karl Trimble, MD (NPI: 1184616880) practices dermatology in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is DIXIE DERMATOLOGY A PROFESSIONAL CORPORATION (NPI: 1356478101; TIN: 201766124) and primary practice location at 84790-7202.

Trimble's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,055 traditional Medicare patients, billed 11,082 HCPCS/CPT codes, and received $782,021 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 781 prescription claims across 451 beneficiaries totaling $16,672 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 2 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $40,923 to $16,672. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$501K$1.0M2015 Medicare payment: $624,259 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $660,006 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $707,577 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $683,791 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $751,786 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $567,463 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,001,942 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $894,580 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $829,372 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $782,021 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,57416,393$624,259
20161,67717,734$660,006
20171,76718,900$707,577
20181,71917,083$683,791
20191,57716,054$751,786
20201,24111,590$567,463
20211,17113,970$1,001,942
20221,14212,070$894,580
20231,13111,739$829,372
20241,05511,082$782,021

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$41K2015 Drug cost: $40,923 (USD; Tot_Drug_Cst)2016 Drug cost: $35,182 (USD; Tot_Drug_Cst)2017 Drug cost: $32,182 (USD; Tot_Drug_Cst)2018 Drug cost: $27,295 (USD; Tot_Drug_Cst)2019 Drug cost: $24,751 (USD; Tot_Drug_Cst)2020 Drug cost: $19,003 (USD; Tot_Drug_Cst)2021 Drug cost: $16,781 (USD; Tot_Drug_Cst)2022 Drug cost: $12,024 (USD; Tot_Drug_Cst)2023 Drug cost: $24,812 (USD; Tot_Drug_Cst)2024 Drug cost: $16,672 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015367622$40,923
2016407674$35,182
2017396651$32,182
2018404670$27,295
2019391604$24,751
2020333534$19,003
2021358610$16,781
2022431755$12,024
2023473882$24,812
2024451781$16,672

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths8481,479$111
17110Destruction of skin growth, 1-14 growths424566$82
11102Biopsy of related skin growth, first growth513781$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7011,177$58
17000Destruction of precancer skin growth, 1 growth391548$37

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole22740$1,582
Clobetasol PropionateClobetasol Propionate20580$1,404
KetoconazoleKetoconazole962,555$1,352
FluorouracilFluorouracil20601$1,107
Triamcinolone AcetonideTriamcinolone Acetonide2526,435$1,093

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$111Incyte Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Karl Kirk Trimble, MD?

Tedicare shows public-source Medicare data for Karl Kirk Trimble, MD (NPI 1184616880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karl Kirk Trimble, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Karl Kirk Trimble, MD?

Karl Kirk Trimble, MD is linked to DIXIE DERMATOLOGY A PROFESSIONAL CORPORATION (billing NPI 1356478101) in the available physician profile data.

Does Karl Kirk Trimble, MD have Open Payments data?

Karl Kirk Trimble, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.